Monthly Communication Report

Organization:	Heart and Stroke Foundation of Canada/Fondation des maladies du coeur et de l’AVC
Associated registration:	946004-119-58
Communication date:	2023-03-06
Posted date:	2023-04-16

Designated Public Office Holders who participated in the communication:	Margaret Sharp, Director Office of Pharmaceutical Management Strategies, Health Canada (HC) Michelle Bourdreau, Executive Director Office of Pharmaceutical Management Strategies, Health Canada (HC) Jessica Burnett, Senior Policy Analyst Office of Pharmaceutical Management Strategies, Health Canada (HC) Amanda Pinke, Senior Policy Analyst Office of Pharmaceutical Management Strategies, Health Canada (HC) Jennifer Boutin, Acting Director Canada Drug Agency Transition Office, Health Canada (HC) Lisa Thompson, Senior Policy Analyst Office of Pharmaceutical Management Strategies, Health Canada (HC) Bobby Chauhan, Director Office of Pharmaceutical Management Strategies, Health Canada (HC)
Subject Matter of the communication:	Health
Responsible Officer who filed this communication report:	Doug Roth
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.